The use of the anti-contraction (tocolytic) drug atosiban in cases of threatened premature birth after 30 weeks of pregnancy is not more effective than placebo at reducing poor […]
A meta- analysis of studies evaluating the efficacy and safety of various glucagon-like peptide-1 receptor agonists (GLP-1 RAs) and co-agonists for treating obesity in adults without diabetes, suggests […]
Use of antibiotics by healthy elderly persons does not cause an increase in the risk of cognitive impairment or dementia, researchers reported on December 18, 2024 in Neurology. […]
Researchers report that an injection of benralizamab administered during some attacks of asthma and COPD, is significantly more effective than current standard treatment with steroid tablets. The findings […]
Researchers report that patients treated with semaglutide have achieved a significantly lower risk of developing Alzheimer’s disease compared to those exposed to seven other anti-diabetic medications, including other […]
Infants fed exclusively with breast milk during their hospitalization at birth are less likely to develop asthma in early childhood, according to research presented on Sept. 27 at […]
Treatment with psilocybin appears to offer long-term antidepressant effects which are comparable to those of standard antidepressant therapy with the SSRI drug escitalopram. Subjects taking psilocybin also reported […]
Treatment with semaglutide and tirzepatide led to significant weight loss and improved blood sugar control in overweight or obese patients with type 1 diabetes (T1D). Researchers reported this […]
Children and adolescents (ages 3-19) worldwide consumed on average 23% more sugar sweetened beverages (SSBs) in 2018 than they did in 1990, researchers reported on August 7, 2024 […]
To treat depression in heart failure, patients can receive with similar efficacy either behavioral activation psychotherapy or antidepressant drug therapy, researchers report. The findings appeared on Jan.17, 2024 […]
Dulaglutide. a Type 2 diabetes treatment, appears to significantly lower the risk of weight gain among women who have stopped smoking, researchers reported after a secondary analysis of […]
Glucagon-like receptor agonists (GLP-1 RAs), a class of type 2 diabetes drug treatments, appear to also reduce the risk of colorectal cancer (CRC) researchers reported on Dec. 7, […]
If you're a healthcare professional you can sign up to our mailing list to receive high quality medical, pharmaceutical and healthcare news and e-journals. Get the latest news and information across a broad range of specialities delivered straight to your inbox.
You can unsubscribe at any time using the 'Unsubscribe' link at the bottom of all our email journals and publications.
